About Us

Supporting The Pharmaceutical And
Biopharmaceutical Industries

We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years; assisting our clients to develop and bring new drugs to market while improving the lives of their patients across the world.

Our History

The Dishman Group was founded in 1983 by Janmejay R. Vyas, Chairman of the Dishman Group. Since its inception, the Dishman Group's focus has been on research and development of various in-house technologies for the manufacture of quaternary ammonium compounds (quats) and active pharmaceutical ingredients.

The Dishman Group's first facility was built in 1987 in Naroda; in 1996 the company initiated its expansion at Bavla, its current headquarters. Through several acquisitions, the Dishman Group spread its reach across the globe with multiple manufacturing facilities in India, Europe and China-serving pharmaceutical and biopharmaceutical companies.

“I saw the need for a company that could provide high-quality, high-value products and services and be a good, reliable partner to pharmaceutical companies worldwide. Having a competitive cost-base and efficient operations is important, but what’s really key is the quality of our people, the service they provide, and the value they offer to our pharmaceutical customers.”
Janmejay R. Vyas

Since then, with the acquisition of Carbogen Amcis AG in 2006 and its vitamin and cholesterol business in 2007, Dishman Carbogen Amcis Ltd has become a global force in innovative product and service and development. Staying true to our founding principles, the business continues to advance with energetic leadership and an unparalleled focus on innovation; with the driving ambition of improving the lives of humankind.

Dishman Carbogen Amcis group facilities, including CARBOGEN AMCIS subsidiary

Bavla
Naroda
Aarau
Bubendorf
Hunzenschwil (Neuland)
Manchester
Riom
Shanghai
Veenendaal
Vionnaz

Our Vision

Our objective is to help our customers create a better world, as the partner of choice for the development and manufacture of complex and challenging substances, highly-potent active ingredients and breaking new ground with innovative vitamin, healthcare and industrial products.

Our Focus: Client Satisfaction

Dishman Carbogen Amcis focusses on the reduction of operational risk in chemical development and commercial manufacturing by:

•• Minimising the time associated with drug development
•• Decreasing the risks associated with drug development
•• Providing long-term and value-added contract manufacturing solutions

Company Profile

CONTACT US TODAY OR DOWNLOAD
OUR COMPANY PROFILE BROCHURE
FOR FURTHER INFORMATION

SUBSCRIBE TO OUR MAILING LIST FOR THE LATEST NEWS UPDATES